Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. USO
7. GOOGL
8. HOOD
9. DFTX
10. IBM

Go back to Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
(NASDAQ: SNDX) Delayed: 19.32 +0.32 (1.68%)
Previous Close $19.00    52 Week High $18.03 
Open $19.21    52 Week Low $8.97 
Day High $19.59    P/E N/A 
Day Low $18.94    EPS $0.00 
Volume 1,836,656